MGNX Receives $24.5M Milestone
MacroGenics to receive $24.5M milestone from Sanofi following FDA approval of TZIELD expansion in type 1 diabetes
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
MGNX Receives Milestone
MacroGenics to receive milestone payment from Sanofi for recent TZIELD approval